COVID-19 drug was approved by China.

According to the online survey, the drugs currently approved for marketing in COVID-19 include Mindevio, nimatinib/ritonavir, monoclonal antibody ravel, azvudine, sanotinib/ritonavir and leritinib. Among them, Mingdewei has a good reputation. Many hospitals in Shanghai are used for clinical treatment of COVID-19, and the possibility of drug interaction is very low. However, the specific medication should be selected reasonably according to the course of the patient.